Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in liver cells: a new clinicopathologic entity with a report of 12 cases. Medicine (Baltimore). 1954;33(3):155-97.

Cebrián García A, Ruiz-Clavijo García D, Larrea Ramírez A, et al. Dubin-Johnson syndrome as a laparoscopic finding. Rev Esp Enferm Dig. 2021;113(8):610-1.

Zhao C, Shi X, Zhang Y, Huang H. Case report: Three novel pathogenic ABCC2 mutations identified in two patients with Dubin-Johnson syndrome. Front Genet. 2022;13:895247.

Paulusma CC, Kool M, Bosma PJ, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology. 1997;25(6):1539-42.

Talaga ZJ, Vaidya PN. Dubin-Johnson syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.

Kim SU, Han KH, Ahn SH. Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol. 2010;16(41):5173-80.

Dadhwal US, Kumar V. Benign bile duct strictures. Med J Armed Forces India. 2012;68(3):299-303.

Hunter FM, Sparks RD, Flinner RL. Hepatitis with resulting mobilization of hepatic pigment in a patient with Dubin-Johnson syndrome. Gastroenterology. 1964;47:631-5.

Ware AJ, Eigenbrodt EH, Shorey J, et al. Viral hepatitis complicating the Dubin-Johnson syndrome. Gastroenterology. 1972;63(2):331-9.

Varma RR, Grainger JM, Scheuer PJ. A case of the Dubin-Johnson syndrome complicated by acute hepatitis. Gut. 1970;11(10):817-21.

Wu L, Li Y, Song Y, et al. A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China. Orphanet J Rare Dis. 2020;15(1):74.

Nies AT, Keppler D. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 2007;453(5):643-59.

Chen ZS, Tiwari AK. Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases. FEBS J. 2011;278(18):3226-45.

Laouari D, Yang RC, Veau C, et al. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am J Physiol Renal Physiol. 2001;280:F636-45.

Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24(2):198-211.

Wang R, Wu Y, Zheng B, et al. Clinicopathological characteristics and prognosis of hepatitis B-associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection. Sci Rep. 2021;11(1):18407.

Hernández-Rodríguez J, Alba MA, Prieto-González S, et al. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014;48–49:84–9.

Singh A, Koritala T, Jialal I. Unconjugated hyperbilirubinemia. 2019.

Khan S, Ali D, Rehman SU. A case report of unexplained persistent conjugated hyperbilirubinemia with normal liver transaminases over 23 years: remember Dubin-Johnson syndrome. J Rare Dis. 2023;2(1):10.

Marschall HU, Wagner M, Zollner G, et al. Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans. Digestion. 2012;86(3):244–9.

Siddiqui AH, Alsabe MR, Tehseen Z, et al. Dubin-Johnson syndrome: A case report. Cureus. 2023;15(3):e36115.